Pharmacology III MD0806

✍ Scribed by US Army medical department

• Publisher: US Army medical department
• Year: 2006
• Tongue: English
• Leaves: 179
• Series: US Army medical course
• Edition: 100
• Category: Library

✦ Table of Contents

TABLE OF CONTENTS
INTRODUCTION
LESSON 1
THE RESPIRATORY SYSTEM
INTRODUCTION
COMPONENTS AND SUBDIVISIONS OF THE HUMAN RESPIRATORY SYSTEM
SUPRALARYNGEAL STRUCTURES
LARYNX
INFRALARYNGEAL STRUCTURES
BREATHING AND BREATHING MECHANISMS IN HUMANS
INTRODUCTION
COSTAL (THORACIC) BREATHING
DIAPHRAGMATIC (ABDOMINAL) BREATHING
CONDITIONS AFFECTING THE RESPIRATORY SYSTEM
INTRODUCTION
PNEUMONIA
ASTHMA
STATUS ASTHMATICUS
EMPHYSEMA
PULMONARY EDEMA
RESPIRATORY SYSTEM DRUGS
INTRODUCTION
ANTITUSSIVE AGENTS
EXPECTORANT AGENTS
ANTITUSSIVE-EXPECTORANT COMBINATION PRODUCTS
MUCOLYTICS
BRONCHODILATOR AGENTS
EXERCISES
SOLUTIONS
LESSON 2
INTRODUCTION
NEED FOR CIRCULATORY SYSTEMS
BASIC COMPONENTS OF ANY CIRCULATORY SYSTEM
CIRCULATORY SYSTEMS IN THE HUMAN BODY
THE HUMAN CARDIOVASCULAR SYSTEM
GENERAL
BLOOD
BLOOD VESSELS
BLOOD CLOTTING
MECHANISMS OF BLOOD CLOTTING
BLOOD PRESSURE
ABNORMAL BLOOD PRESSURE
DISORDERS WHICH AFFECT THE BLOOD SYSTEM
DISORDERS ASSOCIATED WITH THE CIRCULATORY SYSTEM
VASCULAR DISORDERS
BONE MARROW DEPRESSION
THE HEART AND THE SYSTEMIC CIRCULATION OF BLOOD
THE HEART
THE PROPERTY OF INHERENT RHYTHMICITY
THE HEARTBEAT
ELECTROLYTES OF SIGNIFICANCE IN HEART FUNCTIONING
CARDIAC DISORDERS
CARDIOVASCULAR CIRCULATORY PATTERNS
THE HUMAN LYMPHATIC SYSTEM
GENERAL
STRUCTURES OF THE HUMAN LYMPHATIC SYSTEM
EXERCISES
SOLUTIONS
LESSON 3
CONGESTIVE HEART FAILURE AND ITS TREATMENT
INTRODUCTION
REVIEW OF CONGESTIVE HEART FAILURE
TREATMENT OF CONGESTIVE HEART FAILURE
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE INHIBITORS)
DIGITALIS AND THE RELATED GLYCOSIDES
DIGITALIZING DOSE
DIGITALIS PRODUCTS
OTHER AGENTS USED IN CONGESTIVE HEART FAILURE
THE ANTIARRHYTHMIC AGENTS
REVIEW OF CARDIAC ARRHYTHMIAS
THE USE OF ANTIARRHYTHMIC DRUGS
SPECIFIC ANTIARRHYTHMIC DRUGS
ANTIHYPERLIPIDEMIC AGENTS
REVIEW OF ATHEROSCLEROSIS
DEFINITIONS
RISK FACTORS
TREATMENT
EXERCISES
SOLUTIONS
LESSON 4
DEFINITIONS
INTRODUCTION
IMPORTANT TERMS AND THEIR DEFINITIONS
VASODILATOR DRUGS
INTRODUCTION
SMOOTH MUSCLE RELAXANT VASODILATORS
AUTONOMIC NERVOUS SYSTEM VASODILATORS
EXERCISES
SOLUTIONS
LESSON 5
DEFINITIONS
INTRODUCTION
DEFINITIONS
COAGULANTS
REVIEW OF THE CLOTTING PROCESS
COAGULANTS (PROMOTING CLOT FORMATION)
ANTICOAGULANTS
INTRODUCTION
IMPORTANT WARNING ASSOCIATED WITH THE ANTICOAGULANTS
ANTICOAGULANT AGENTS
HEMATINICS
INTRODUCTION
HEMATINIC AGENTS
STIMULATING FACTORS
INTRODUCTION
EXERCISES
SOLUTIONS
LESSON 6
OVERVIEW OF THE UROGENITAL SYSTEMS
INTRODUCTION
DISCUSSION OF LESSON CONTENT
THE HUMAN URINARY SYSTEM
INTRODUCTION
THE HUMAN URINARY SYSTEM
THE KIDNEY
HORMONES INVOLVED IN THE FORMATION OF URINE
URETERS
URINARY BLADDER
URETHRA
URINARY TRACT DISORDERS
INTRODUCTION TO HUMAN GENITAL (REPRODUCTIVE) SYSTEMS
SEXUAL DIMORPHISM
ADVANTAGES OF DOUBLE PARENTING
MAJOR COMPONENT CATEGORIES OF THE GENTIAL SYSTEMS
THE HUMAN FEMALE GENITAL (REPRODUCTIVE) SYSTEM
PRIMARY SEX ORGANS (OVARIES)
SECONDARY SEX ORGANS
SECONDARY SEXUAL CHARACTERISTICS
MAMMARY GLANDS
THE HUMAN MALE GENITAL (REPRODUCTIVE) SYSTEM
PRIMARY SEX ORGANS (TESTES)
SECONDARY SEX ORGANS
SECONDARY SEXUAL CHARACTERISTICS
EXERCISES
SOLUTIONS
LESSON 7
INTRODUCTION TO HYPERTENSION
INTRODUCTION
TREATMENT OF HYPERTENSION
DEFINITION OF ESSENTIAL (PRIMARY) HYPERTENSION
CLASSES OF ESSENTIAL HYPERTENSION
REVIEW OF IMPORTANT FACTORS RELATING TO HYPERTENSION
DIURETICS IN THE TREATMENT OF HYPERTENSION
COMBINATION THERAPY IN THE TREATMENT OF HYPERTENSION
DRUGS USED IN THE TREATMENT OF HYPERTENSION
DRUGS WHICH ACT ON THE SYMPATHETIC NERVOUS SYSTEM
BETA ADRENERGIC BLOCKERS
SMOOTH MUSCLE RELAXANTS
COMBINATION PRODUCTS
THE TREATMENT OF A HYPERTENSIVE CRISIS OR EMERGENCY
EXERCISES
SOLUTIONS
LESSON 8
DIURETIC AGENTS
INTRODUCTION
DEFINTION OF DIURETIC
USES OF DIURETICS
TYPES OF DIURETICS
ANTIDIURETIC AGENTS
INTRODUCTION
MECHANISM OF ACTION OF ANTIDIURETICS
EXAMPLES OF ANTIDIURETIC AGENTS
EXERCISES
SOLUTIONS
LESSON 9
INTRODUCTION
GENERAL
DEFINITIONS
CAUSES OF POISONING
THE PHARMACY AND POISON PREVENTION
THE POISON PREVENTION PACKAGING ACT OF 1970
THE REQUIREMENTS OF THE POISON PREVENTION PACKAGING ACT OF 1970
EXCEPTIONS TO THE ACT
CONSIDERATIONS FOR THE OUTPATIENT PHARMACY
THE TREATMENT OF POISONING
INTRODUCTION
TREATMENT GUIDELINES FOR POISONING VICTIMS
POISON CONTROL AND INFORMATION
INTRODUCTION
POISON INFORMATION/CONTROL CENTERS
SUGGESTED REFERENCES TO BE MAINTAINED IN THE PHARMACY IN RELATION TO POISONING INFORMATION
CONCLUDING COMMENTS
EXERCISES
SOLUTIONS
ANNEX
COMMENT SHEET